🔗 Share this article

An underground economy for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Experimental Drug Acquiring Popularity Online

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Followers are urged to message these profiles privately for supplier links, while also receiving discount codes.

Active Trade on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where groups with thousands of members share “before and after” photos, injection guides and claims of next-day UK delivery. Vendors market the drug there before directing buyers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Experts Express Worries

Nevertheless, physicians and pharmacists have warned that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could result in users injecting substances of unknown origin.

Some experts said the demand for the experimental drug could be connected to the rising cost of licensed slimming treatments such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still violate medicines, marketing, and customer regulations, potentially leading to penalties, prosecution or prison.

Service Reaction and Material Removal

According to the social media company, the service has removed problematic content and banned associated keywords and search suggestions. The organization said it was dedicated to keeping the platform secure and allocating resources in strengthening enforcement strategies.

Online Marketplace Operations

Investigations also found communities with up to 9,000 participants selling the experimental drug using Telegram's built-in search feature, which functions like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of users, populated with images of weight loss, positive testimonials and detailed instructions for mixing or injecting at residence.

Within minutes of joining one community, a vendor posted contact information, where the majority of purchases occur. The seller sent an guidebook and promised shipping within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about body mass, medical conditions or past usage.

Product Details and Costs

Within these communities, posts display dark colored parcels with postal service labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with sterile water, or ready-to-use pens usually sold at £160 for 20 milligrams. When questioned how much time a pen should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.

Service Moderation and Security Actions

A spokesperson for Telegram said it actively moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are injecting substances they can’t verify. Even if the research behind retatrutide is sound, these digital products may not contain what they advertise,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent price rises for authorized slimming medications such as Mounjaro. “With costs rising, patients are turning to social media. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said.

Her team has already seen individuals injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly stated the substance was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a company experimental product not yet authorized … may expose users to potentially serious medical dangers”.